Review
Copyright ©2009 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Jun 28, 2009; 15(24): 2975-2979
Published online Jun 28, 2009. doi: 10.3748/wjg.15.2975
Eosinophilic colitis
Nnenna Okpara, Bassam Aswad, Gyorgy Baffy
Nnenna Okpara, Gyorgy Baffy, Division of Gastroenterology, Department of Medicine, Rhode Island Hospital and Alpert Medical School of Brown University, Providence, Rhode Island, MA 02130, United States
Bassam Aswad, Department of Pathology, Rhode Island Hospital and Alpert Medical School of Brown University, Providence, Rhode Island, MA 02130, United States
Author contributions: Okpara N acquired the data, drafted the manuscript; Aswad B participated in acquiring the data and reviewing the manuscript; Baffy G designed the study and finally approved the finial version.
Correspondence to: Gyorgy Baffy, MD, PhD, Section of Gastroenterology, VA Boston Healthcare System, 150 S Huntington Ave, Rm A6-46, Boston, MA 02130, United States. gbaffy@partners.org
Telephone: +1-857-3644327  
Fax: +1-857-3644179
Received: December 17, 2008
Revised: April 3, 2009
Accepted: April 10, 2009
Published online: June 28, 2009
Abstract

Eosinophilic colitis (EC) is a rare form of primary eosinophilic gastrointestinal disease with a bimodal peak of prevalence in neonates and young adults. EC remains a little understood condition in contrast to the increasingly recognized eosinophilic esophagitis. Clinical presentation of EC is highly variable according to mucosal, transmural, or serosal predominance of inflammation. EC has a broad differential diagnosis because colon tissue eosinophilia often occurs in parasitic infection, drug-induced allergic reactions, inflammatory bowel disease, and various connective tissue disorders, which require thorough searching for secondary causes that may be specifically treated with antibiotics or dietary and drug elimination. Like eosinophilic gastrointestinal disease involving other segments of the gastrointestinal tract, EC responds very well to steroids that may be spared by using antihistamines, leukotriene inhibitors and biologics.

Keywords: Eosinophilia, Colitis, Gastrointestinal disease, Ascites